PURE Bioscience, Inc. (PURE) Comparison with companies in other sectors?

PURE Bioscience, Inc. has a share price of 111.89M. You can analyze PURE Bioscience, Inc. (PURE) competitors across different market sectors through stock heatmaps.

What are PURE's NET and operating margins?

PURE Bioscience, Inc. (PURE) operating margin is around -1.35, and net profit margin is approximately -1.48 as of the latest reports.

In what way does PURE's earnings per share (EPS) trend reflect its financial momentum?

PURE Bioscience, Inc. (PURE) EPS is -0.02 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for PURE Bioscience, Inc. is -3.68, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for PURE Bioscience, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for PURE Bioscience, Inc. like P/E which is -2.92, P/B which is -1.71, and PEG which is -0.32. Compare them with sector averages to evaluate if the stock is priced fairly.

PURE Bioscience, Inc.

PURE•PNK

Consumer Defensive

Household & Personal Products

$0.07

$0.003(3.88%)

PURE Bioscience, Inc. (PURE) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.02

P/E Ratio

-3.68

ROE

0.83%

Net Margin

-1.48%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$8.23M

Shares OutstandingTotal number of shares issued

$111.89M

Book Value/ShareNet worth per share

$-0.04

Revenue/ShareAnnual revenue per share

$0.02

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.02

Net MarginNet income as percentage of revenue

-147.65%

Operating MarginOperating income as percentage of revenue

-134.68%

ROEReturn on shareholders' equity

82.64%

ROAReturn on total assets

-267.08%

ROCEReturn on capital employed

-3029.41%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.02

Cash/ShareCash and equivalents per share

$0.005

FCF YieldFree cash flow as percentage of market cap

-26.13%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for PUREFinancial Ratios Analysis details for PURE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PURESector Benchmarking details for PURE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for PURE Bioscience, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of PURE Bioscience, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account PURE Bioscience, Inc.'s unique business strengths and challenges.

Key Financial Metrics for PURE Bioscience, Inc.

For PURE Bioscience, Inc., essential financial indicators include EPS -0.02, PE -3.68, and ROE 0.83. These key ratios reveal insights into PURE Bioscience, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare PURE Bioscience, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of PURE Bioscience, Inc.

Metrics like Net Margin -147.65% and ROA -267.08% shed light on how well PURE Bioscience, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether PURE Bioscience, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of PURE Bioscience, Inc.

Using ratios such as P/B Ratio -1.71 and PEG Ratio -0.32, investors can assess whether PURE Bioscience, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with PURE Bioscience, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for PURE Bioscience, Inc.

Financial health indicators, such as Debt/Equity Ratio -1.02 and Cash Flow $-0.02, provide a snapshot of PURE Bioscience, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like PURE Bioscience, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for PURE Bioscience, Inc.

Investing in PURE Bioscience, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at PURE Bioscience, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;